The inside story from Aspen on Covid-19 Dexamethasone: MUST LISTEN

Loading player...
This week, the world woke up to the exciting news that Dexamethasone, a cheap drug in the Aspen stable, dramatically improves the chances of survival for people seriously ill in hospitals with Covid-19. The Aspen share price has jumped up in value on the Johannesburg stock exchange as investors anticipate high demand for Dexamethasone. In this interview with BizNews founder Alec Hogg, Aspen group senior executive Stavros Nicolaou shares the details of what is known about Dexamethasone and how it will be made available. Learn more about your ad choices. Visit megaphone.fm/adchoices
17 Jun 2020 2PM English South Africa Investing · Business News

Other recent episodes

BN Daybreak Thurs 15 Jan: Abedian on SA Silence about “21st Century Nazis”; Mining Indaba's back story; Sasol Surges

In this morning's briefing, Alec Hogg unpacks a volatile geopolitical landscape where conflicting reports emerge from Iran—Donald Trump claims de-escalation while internal memos suggest mass casualties. We speak to Iranian-born and bred entrepreneur and former UCT Economics Prof Iraj Abedian, who delivers a scathing critique of the South African government's…
14 Jan 11PM 17 min

BN Briefing: Leaked Iran death toll, US-SA relations, and Equities vs Gold

In this BizNews Briefing, Dr. Iraj Abedian reveals leaked reports of 12,000 deaths in Iran, questioning the South African government’s silence. The Hudson Institute's Josh Meservey analyses Pretoria’s alignment with American adversaries. Plus, David Shapiro discusses the "survival mode" of South African business, and Peter Major explains why equities historically…
14 Jan 5AM 13 min